Boehringer Ingelheim India is taking a 2-pronged approach to addressing this epidemic
According to the World Health Organization, India accounts for 36% of the world’s rabies deaths with an estimated 18,000 to 20,000 deaths from this disease each year.1 To address this major public health crisis, Boehringer Ingelheim India has entered into a Memorandum of Understanding (MoU) with Pet Practitioners Association of Mumbai (PPAM), a non-profit charitable organization with the goal of eliminating rabies in the Greater Mumbai area.
A company release2 states that the 'Stop Rabies' initiative is in tandem with India's National Action Plan for Dog-Mediated Rabies Elimination by 2030. Boehringer Ingelheim India has committed to donate 30,000 doses of its anti-rabies vaccine, Rabisin (inactivated and adjuvanted rabies glycoproteins) for free vaccination camps that will be run with the support of Brihanmumbai Municipal Corporation (BMC). The company will also lead a month-long awareness drive in collaboration with PPAM in schools and communities to inform the public on rabies prevention and the human-animal bond.
The MoU signing was recently held in Mumbai between PPAM represented by Dhananjay Bapat, BVSc & AH, president, PPAM and Makrand Chavan, BVSc & AH, MVSc, secretary, PPAM; and Boehringer Ingelheim India represented by Gagandeep Singh Bedi, managing director and head of human pharma and Vinod Gopal, DVM, MBA, director - country head, animal health.
"Rabies, a disease that can be prevented by vaccination, continues to be a problem for public health," said Gopal.2 "Adopting the 'One Health' approach will be key to securing a healthier future for all. Our 'Stop Rabies' initiative with PPAM and BMC is a step in that direction, showcasing our commitment to the well-being of humans and uncared dogs and cats."
"Eliminating rabies in Mumbai is crucial for public health. The 'Stop Rabies' initiative stands as a testament to the power of public-private partnerships, and empowering Mumbai to move closer to becoming rabies-free," added Bapat, in the release.
References
UN, WHO address public health concern over avian flu transmission to humans
April 18th 2024Veterinary professionals working with certain animals are advised to take precautionary steps to minimize risk of infection, while researchers in Texas study potential H5N1 vaccines, antivirals, and antibody therapies for humans
Read More